Key facts
- Notable investors include Mission BioCapital, Roche Venture Fund.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Merge Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Merge Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Merge Therapeutics
Operator of a biotechnology company intended to accelerate therapeutic research and development. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Mill Valley, CA, United States
- Founded
- 2024
- Website
- mergetx.com/
- Ownership
- Privately Held (backing)
Merge Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Merge Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Merge Therapeutics in its N-PORT filings yet. We sweep new filings monthly.